Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 2
2010 5
2011 2
2012 2
2013 2
2015 3
2016 3
2017 7
2018 7
2019 4
2020 8
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean mingxi xu (33 results)?
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J. Pagès F, et al. Among authors: xu m. Lancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789-X. Epub 2018 May 10. Lancet. 2018. PMID: 29754777
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.
Mlecnik B, Bifulco C, Bindea G, Marliot F, Lugli A, Lee JJ, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Lafontaine L, Bruni D, Lanzi A, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Paustian C, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Muşină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Fox BA, Pagès F, Galon J. Mlecnik B, et al. Among authors: xu m. J Clin Oncol. 2020 Nov 1;38(31):3638-3651. doi: 10.1200/JCO.19.03205. Epub 2020 Sep 8. J Clin Oncol. 2020. PMID: 32897827
Patterning a Leaf by Establishing Polarities.
Manuela D, Xu M. Manuela D, et al. Among authors: xu m. Front Plant Sci. 2020 Oct 30;11:568730. doi: 10.3389/fpls.2020.568730. eCollection 2020. Front Plant Sci. 2020. PMID: 33193497 Free PMC article. Review.
Interleukins and cancer immunotherapy.
Yoshimoto T, Morishima N, Okumura M, Chiba Y, Xu M, Mizuguchi J. Yoshimoto T, et al. Among authors: xu m. Immunotherapy. 2009 Sep;1(5):825-44. doi: 10.2217/imt.09.46. Immunotherapy. 2009. PMID: 20636026 Review.
Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases.
Chiba Y, Mizoguchi I, Hasegawa H, Ohashi M, Orii N, Nagai T, Sugahara M, Miyamoto Y, Xu M, Owaki T, Yoshimoto T. Chiba Y, et al. Among authors: xu m. Cell Mol Life Sci. 2018 Apr;75(8):1363-1376. doi: 10.1007/s00018-017-2724-5. Epub 2017 Dec 7. Cell Mol Life Sci. 2018. PMID: 29218601 Review.
Antitumor activities of interleukin-27 on melanoma.
Nagai H, Oniki S, Fujiwara S, Xu M, Mizoguchi I, Yoshimoto T, Nishigori C. Nagai H, et al. Among authors: xu m. Endocr Metab Immune Disord Drug Targets. 2010 Mar;10(1):41-6. doi: 10.2174/187153010790827920. Endocr Metab Immune Disord Drug Targets. 2010. PMID: 19845503 Review.
EBV-induced gene 3 augments IL-23Rα protein expression through a chaperone calnexin.
Mizoguchi I, Ohashi M, Hasegawa H, Chiba Y, Orii N, Inoue S, Kawana C, Xu M, Sudo K, Fujita K, Kuroda M, Hashimoto SI, Matsushima K, Yoshimoto T. Mizoguchi I, et al. Among authors: xu m. J Clin Invest. 2020 Nov 2;130(11):6124-6140. doi: 10.1172/JCI122732. J Clin Invest. 2020. PMID: 32809973 Free PMC article.
Potential clinical application of interleukin-27 as an antitumor agent.
Yoshimoto T, Chiba Y, Furusawa J, Xu M, Tsunoda R, Higuchi K, Mizoguchi I. Yoshimoto T, et al. Among authors: xu m. Cancer Sci. 2015 Sep;106(9):1103-10. doi: 10.1111/cas.12731. Epub 2015 Aug 6. Cancer Sci. 2015. PMID: 26132605 Free PMC article. Review.
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page